UCL to co-lead Prostate Cancer UK’s new £42m screening trial

FHS
May 2, 2024
4:52 am

UCL academics will co-lead Prostate Cancer UK’s new £42m screening trial, which aims to find the best way to screen men for prostate cancer and double the number of lives saved.

Liquid biopsies could be used as an early marker of immunotherapy response, study finds

Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream by dying cancer cells).

October 10, 2023

ABBV-400 by AbbVie for Metastatic Hepatocellular Carcinoma (HCC): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 21, 2023

COVID-19 pandemic has increased mental health burden on family and friends of patients

Family members and close friends of people with COVID-19 have elevated symptoms of depression and anxiety, a study from Karolinska Institutet published in The Lancet

September 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.